heptapeptide raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
This page was last updated on 2026-01-21 and is reviewed periodically as new material appears.
The mechanisms attributed to semax are inferred from animal and cell studies rather than traced to one confirmed target. The most frequently cited pathway involves increased expression of brain-derived neurotrophic factor and nerve growth factor in hippocampal and cortical tissue. Some work points to engagement of melanocortin receptors, particularly MC4, which the parent ACTH fragment can activate. Effects on dopaminergic and serotonergic signalling have also been reported. No single account explains all observed results, and the relative weight of each pathway remains unsettled.
Published studies examine a fairly narrow set of endpoints. Rodent experiments commonly measure maze learning, infarct volume after induced ischemia, and tissue levels of neurotrophic factors. Clinical reports from Russian centres describe attention, memory and recovery scores in patients after stroke or transient ischemic attack. Most of those human studies are small and few have been repeated by independent groups. Outcome measures differ between studies, which limits direct comparison.
Semax is a synthetic heptapeptide with the sequence Met-Glu-His-Phe-Pro-Gly-Pro. It corresponds to the ACTH(4-7) fragment extended at the C-terminus by a Pro-Gly-Pro tripeptide, an addition intended to slow enzymatic breakdown. The molecular formula is C37H51N9O10S and the molecular mass is approximately 814 daltons. In the literature it is often described as an ACTH(4-10) analog, although that label reflects a naming convention as much as a precise structural relationship. The compound was developed in Russia and remains most closely associated with that research tradition.
Laboratory descriptions of the material are consistent across suppliers. It appears as a white to off-white lyophilized powder that dissolves readily in water and in polar organic solvents such as dimethyl sulfoxide. Aqueous solutions are clear and colorless at low concentrations. Because the peptide contains methionine, oxidation at the sulfur atom is a recognized degradation pathway, and handling notes usually call for protected, desiccated storage. Reported purity for research-grade lots is generally above 95 percent as measured by reversed-phase high-performance liquid chromatography.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off-white powder | Lyophilized solid from research suppliers |
| Solubility | Freely soluble in water | Also dissolves in aqueous buffers; solutions are used fresh |
| Typical storage temperature | -20 °C for lyophilized powder | Short-term transport at 2-8 °C is common |
| Common analytical method | Reverse-phase HPLC | Paired with mass spectrometry for identity confirmation |
| Common synonyms | ACTH(4-10) analogue; MEHFPGP | N-terminal methionine retained in the chain |
Routine characterization relies on reversed-phase high-performance liquid chromatography to establish purity and on mass spectrometry to confirm molecular identity. Electrospray ionization and matrix-assisted laser desorption ionization are both used for mass verification. Amino acid analysis and peptide mapping can detect sequence errors. Common impurities include truncated sequences, methionine sulfoxide formed by oxidation, and deamidated products. Chromatograms are usually recorded near 214 nm, where the peptide backbone absorbs, and purity is reported as the percentage area of the principal peak.
Verification of a supplied batch generally combines a certificate of analysis with independent testing, because certificates are self-reported documents. A typical package includes a chromatographic trace, a mass spectrum, and a stated water or counter-ion content. Batch-to-batch consistency matters more than a single purity figure when results are compared across experiments. No single mandatory standard governs research-grade peptide release, so laboratories are expected to define their own acceptance criteria. Residual trifluoroacetate from purification is a frequently overlooked counter-ion.
The compound was developed in the 1980s at the Institute of Molecular Genetics in Moscow, where it emerged from research on short ACTH fragments and their effects on the central nervous system. Russian pharmaceutical listings describe it as a nootropic and neuroprotective agent, most often formulated as nasal drops. It is not a marketed medicine in the United States or the European Union, and no pharmacopoeial monograph covers it. Consequently, most published clinical experience with the substance originates from a small number of research centres, mainly in Russia and neighbouring countries.
Pharmacological accounts link semax to melanocortin signalling and to modulation of neurotrophic factor expression, particularly brain-derived neurotrophic factor and nerve growth factor. Much of this evidence comes from rodent studies using intranasal delivery, a route chosen because it allows peptides to reach the central nervous system with limited systemic exposure. Whether the same mechanisms operate in humans at comparable magnitude remains an open question. The precise receptor or receptors responsible for the reported behavioural and neuroprotective effects have not been conclusively identified.
Clinical reports describe use in ischaemic stroke, transient ischaemic attack, optic nerve conditions, and cognitive complaints, but most of these studies are small and were conducted in a single region. Systematic reviews have generally described the evidence base as limited in size and variable in methodological quality. Randomised controlled data suitable for international regulatory assessment are scarce. As a result, major treatment guidelines outside Russia do not include the peptide, and interest in it remains largely research-driven rather than routine clinical.
== Function == Foreign body giant cells are involved in the foreign body reaction, phagocytosis, and subsequent degradation of biomaterials which may lead to failure of the implanted material. When produced, the FBGC's place themselves along the surface of the implantation, and will remain there for as long as the foreign material remains in the body. Macrophages and FBGC's will begin to produce inflammatory molecules in response to the biomaterial. These inflammatory molecules will signal other molecules to respond and begin the process of wound healing. Microorganisms, particles, and debris that were produced from inserting the biomaterial may be engulfed by macrophages. If the substance is too large for one macrophage, the FBGC's can attempt to engulf the foreign material for degradation.
Eliminates competition between male and female Osedax as resources are limited, Sessile lifestyle: attach to and rely on females for food, Decreases difficulty in finding a mate. Interestingly, Osedax priapus lack the frequently observed male dwarfism. Males live freely and compete for space and food with females. Being larger, they produce and carry more sperm. However, sexual size dimorphism is still observed in O. priapus: most males are one-third the volume of females. Annelid sex is typically determined by genetic factors, however models of environmental sex determination have been proposed for Osedax, in which larvae that settle on bones mature into females, while larvae that settle on female Osedax do not fully develop and mature into males. Osedax japonicus in particular has showcased an environmental form of sex determination.
=== Relation to beta thalassemia === Delta-beta thalassemia can mask the diagnosis of beta thalassemia trait. In beta thalassemia, an increase in hemoglobin A2 results, but the co-existence of a delta-beta thalassemia mutation will decrease the value of the hemoglobin A2 into the normal range, thereby obscuring the diagnosis of beta thalassemia trait
Sources: en.wikipedia.org
Low genetic variation was found to occur between the three song characteristics in C. brunneus and C. jacobsi and no sex linkage was found. Peg numbers on the stridulatory file, while different between the two species, are surprisingly not dependent on song characteristics. Genetics cannot account for the difference in peg number. Instead additive effects explain the phenotypic variation in both song characteristics and peg number between C. brunneus, C. jacobsi, and their hybrids.
== Activation == Chymotrypsinogen must be inactive until it gets to the digestive tract, in order to prevent damage to the pancreas or any other organs. It is activated by another enzyme called trypsin. The active form is called π-chymotrypsin and is used to create α-chymotrypsin. Trypsin cleaves the peptide bond in chymotrypsinogen between arginine-15 and isoleucine-16. This creates two peptides within the π-chymotrypsin molecule, held together by a disulfide bond. One π-chymotrypsin acts on another by breaking a leucine and serine peptide bond. The activated π-chymotrypsin reacts with other π-chymotrypsin molecules to cleave and remove two dipeptides: serine-14–arginine-15 and threonine-147–asparagine-148. This reaction produces α-chymotrypsin. The yield of α-chymotrypsin can be affected by inhibitors such as hydrocinnate and also by pH, temperature and calcium chloride. The activation process can be studied using fluorescence probe 2-p-toluidinylnaphthalene-6-sulfonate (TNS). TNS forms covalent bonds with chymotrypsinogen and as the bonds break to form chymotrypsin in the presence of trypsin, the fluorescence increases.
=== Surveys and reference === Books Beckert, Sven (2014). Empire of Cotton: A Global History. Knopf Doubleday. ISBN 978-0-385-35325-0. Davies, Stephen (2008). "Slavery, World". In Hamowy, Ronald (ed.). The Encyclopedia of Libertarianism. Thousand Oaks, CA: Sage; Cato Institute. pp. 464–469. doi:10.4135/9781412965811.n285. ISBN 978-1-4129-6580-4. LCCN 2008009151. OCLC 750831024. Davis, David Brion (1988) [1966]. The Problem of Slavery in Western Culture. Oxford: Oxford University Press. ISBN 978-0-19-505639-6. Davis, David Brion (1999). The Problem of Slavery in the Age of Revolution, 1770–1823. Oxford University Press. ISBN 978-0-19-988083-6. Drescher, Seymour (2009). Abolition: A History of Slavery and Antislavery. Cambridge University Press. p. 281. ISBN 978-1-139-48296-7. Eden, Jeff (2018). Slavery and Empire in Central Asia. Cambridge University Press. ISBN 978-1-108-63732-9. Gordon, Murray (1989). Slavery in the Arab World. Rowman & Littlefield. ISBN 978-0-941533-30-0. Greene, Jacqueline Dembar (2001). Slavery in Ancient Egypt and Mesopotamia. Turtleback Books. ISBN 978-0-613-34472-2. Heuman, Gad J. (2003). The Slavery Reader. Psychology Press. ISBN 978-0-415-21304-2. Hogendorn, Jan; Johnson, Marion (2003). The Shell Money of the Slave Trade. Cambridge University Press. ISBN 978-0-521-54110-7. Lal, K.S. (1994). Muslim Slave System in Medieval India. Aditya Prakashan. ISBN 978-81-85689-67-8. Archived from the original on May 12, 2008. Miers, Suzanne; Kopytoff, Igor (1979). Slavery in Africa: Historical and Anthropological Perspectives.
== Etymology == The word pepper derives from Old English pipor, Latin piper, and Greek πέπερι. The Greek likely derives from Sanskrit. In the 16th century, people began using pepper to also mean the New World chilli pepper (genus Capsicum), which is not closely related.
Sources: en.wikipedia.org
== External links == Opioid+Receptors at the U.S. National Library of Medicine Medical Subject Headings (MeSH) "How opioid drugs activate receptors". National Institute of Health. "Opioid Receptors". IUPHAR Database of Receptors and Ion Channels. International Union of Basic and Clinical Pharmacology. Corbett A, McKnight S, Henderson G. "Opioid Receptors". BLTC Research. Retrieved 2008-03-21. Guzman F. "Video lectures on opioid receptors". Pharmacology Corner. Retrieved 2012-07-30. Lomize A, Lomize M, Pogozheva I. "Orientations of Proteins in Membranes (OPM) database". University of Michigan. Archived from the original on 2014-01-03. Retrieved 2008-03-21.
== History == The method of thermospray ionization was first introduced by a patent evidenced as early as 1983, and described in further detail by a patent published on March 8, 1988. Inventors Marvin L. Vestal and Calvin R. Blakley proposed an ion vapor source for mass spectrometry of liquids under a US Grant from the Department of Health, Education, and Welfare. The proposed method detailed a coupling device between liquid chromatographic columns and various methods of detection for gaseous samples; like mass spectrometry, electron capture, atomic adsorption, etc. Four different representations of the thermospray vaporizer were presented in the 1988 patent – UA4730111A. Nonvolatile, ionic, and thermally labile solutes were investigated with the various control systems on the vaporizers to achieve partial vaporization.
Miriam Luke. President, Henley Rowing Club and lately Chair, Henley Women's Regatta. For services to Women's Rowing. Martin Edward Machray. Executive Director of Performance, NHS England, London. For services to Healthcare. Malcolmina Mackay Macleod. Social and Health Carer. For services to the community of North Uist, Scotland. Professor Roma Maguire. Professor of Digital Health and Care, University of Strathclyde. For services to Health Care Research. Helen Ann Maitland. Lately National Director for Urgent and Unscheduled Care, Scottish Government. For services to NHS Scotland. Eric Malcomson. Founder and Chair, Tove Valley Broadband. For services to the community in the Tove Valley, Northamptonshire. Robert James Hammond Malcomson. Deputy Director, Cabinet Office. For public and voluntary service to the LGBTQ+ Community and to Homeless People. Sharon Manning. Cancer Nurse Specialist, Macmillan. For services to Cancer Patient Care. Deirdre Marshall. Team Leader, Ministry of Defence. For services to Defence. Kathryn Julia Marshall. Senior Manager, Lloyds Banking Group, Halifax. For services to Further Education and Skills. Robert James Martin. For services to Drama in Northern Ireland. Elsie Barbara Martlew. Lately Deputy Leader, City of Carlisle Council. For Political and Public Service. Paul Nicholas Martynenko. Vice-President, Registration and Standards, BCS, The Chartered Institute for IT. For services to the Information Technology Industry. Sarah Mason. Chief Executive Officer, Women's Aid Federation Northern Ireland. For services to Women and Girls.
Sources: en.wikipedia.org
It consists mainly of animal experiments and small clinical reports, with much of the clinical material published in Russian-language journals. Large independent trials are scarce. Separating reliable effects from chance findings is consequently difficult.
A fraction of an intranasal dose is thought to reach the central nervous system, and this route is favoured partly for that reason. The proportion is not well characterized. Direct measurement in humans remains difficult with current methods.
Raised BDNF and NGF expression has been reported across several animal studies, which makes the signal fairly consistent. Whether the same change occurs in humans at usable doses is not established. It is best treated as a working hypothesis rather than a confirmed clinical mechanism.
It is registered as a pharmaceutical product in Russia, where it is typically supplied as a nasal solution. In most other countries it is not an approved drug and is traded as a research chemical instead. Approval status depends entirely on the jurisdiction involved.